Document is current
Any future updates will be listed below
-
Authors
Molla, Hanna
DeBrosse, Joseph
Keedy, Sarah https://orcid.org/0000-0002-2139-9271
Lee, Royce
de Wit, Harriet https://orcid.org/0000-0002-7211-8994
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Center for Advancing Translational Sciences (TR002387)
U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse (DA02812)
- License Information
-
More Information
Article History
Received: 6 January 2025
Revised: 9 April 2025
Accepted: 14 April 2025
First Online: 23 April 2025
Competing interests
: HdW is on the Board of Directors of PharmAla Biotech and consultant to Awakn Life Sciences and Gilgamesh Pharmaceuticals. These were unrelated to the present research. HM, JD, SK, and RL report no conflicts.
